Skip to main content
Premium Trial:

Request an Annual Quote

NGeneBio, Genoks Ink Middle East, Western Asia Dx Marketing Deal

NEW YORK — NGeneBio said on Tuesday that it has signed a memorandum of understanding to offer its next-generation sequencing-based diagnostics in the Middle East and western Asia in partnership with Turkish genomics healthcare company Genoks.

Under the terms of the arrangement, South Korea-based NGeneBio will provide its sequencing panels, data analysis software, and nucleic acid extraction systems to Genoks, which will use the technologies to perform diagnostic testing on samples collected from patients in Turkey, Iran, Azerbaijan, and Cyprus.

Financial and other terms of the deal were not disclosed.

NGeneBio, which primarily offers a range of tests for cancer, received CE marking for a tuberculosis assay.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.